Copyright
©The Author(s) 2021.
World J Cardiol. Jul 26, 2021; 13(7): 183-203
Published online Jul 26, 2021. doi: 10.4330/wjc.v13.i7.183
Published online Jul 26, 2021. doi: 10.4330/wjc.v13.i7.183
ACC/AHA Stages of HF | NYHA Functional Classification | Restriction of physical activity | ||
A | At high risk for HF but without structural heart disease or symptoms of HF (e.g., diabetes, arterial hypertension) | / | / | |
B | Structural heart disease but without symptoms of HF | I | Regular physical activity does not cause dyspnea and fatigue – asymptomatic | No limitation of physical activity |
C | Structural heart disease with prior or current symptoms of HF | I | Regular physical activity does not cause dyspnea and fatigue – asymptomatic | No limitation of physical activity |
II | Moderate physical activity results in milder dyspnea and fatigue | Slight limitation of physical activity | ||
III | No difficulty at rest; minimal physical activity leads to exhaustion, dyspnea, and fatigue | Marked limitation of physical activity | ||
IV | Symptomatic at rest | Unable to carry on any physical activity without symptoms of HF | ||
D | Refractory HF requiring specialized interventions | IV | Symptomatic at rest | Unable to carry on any physical activity without symptoms of HF |
Contraindications to exercise training | Increased risk for exercise training |
Progressive worsening of exercise tolerance or dyspnea at rest over previous 3–5 d | > 1.8 kg increase in body mass over the previous 1-3 d |
Significant ischemia during low-intensity exercise (< 2 METs, < 50 W) | Concurrent, continuous, or intermittent dobutamine therapy |
Uncontrolled diabetes | Decrease in systolic blood pressure with exercise |
Recent embolism | NYHA functional class IV |
Thrombophlebitis | Complex ventricular arrhythmia at rest or appearing with exertion |
Supine resting heart rate > 100 b.p.m. | |
Pre-existing co-morbidities limiting exercise tolerance |
- Citation: Sopek Merkaš I, Slišković AM, Lakušić N. Current concept in the diagnosis, treatment and rehabilitation of patients with congestive heart failure. World J Cardiol 2021; 13(7): 183-203
- URL: https://www.wjgnet.com/1949-8462/full/v13/i7/183.htm
- DOI: https://dx.doi.org/10.4330/wjc.v13.i7.183